Hepatitis B vaccine in Saudi children
Author
Source
Issue
Vol. 14, Issue 3 (31 Dec. 1992), pp.86-87, 2 p.
Publisher
King Hamad University Hospital
Publication Date
1992-12-31
Country of Publication
Bahrain
No. of Pages
2
Main Subjects
Abstract EN
The aim of our study is to know the protective efficacy and ؛mmuno§en؛c؛ty ofEngerix B (Recombi-nant Deoxyribonucleic acid-Yeast derived Hepatitis B vaccine).
In 1987,113 seronegative children were vac-cinated intramuscularly in the quadriceps region with 1.0 ml of Engerix B.
Serum samples were collected at month 1,2,7,12 and tested for Anti HBs levels.
The seroconversion rates for HBs Antibodies were 28% at month 1,79% at month 2,94% at month 7 and 92% at month 12.
No significant adverse reactions were no-ticed.
American Psychological Association (APA)
Tunisi, Tahir S.. 1992. Hepatitis B vaccine in Saudi children. Bahrain Medical Bulletin،Vol. 14, no. 3, pp.86-87.
https://search.emarefa.net/detail/BIM-605622
Modern Language Association (MLA)
Tunisi, Tahir S.. Hepatitis B vaccine in Saudi children. Bahrain Medical Bulletin Vol. 14, no. 3 (Dec. 1992), pp.86-87.
https://search.emarefa.net/detail/BIM-605622
American Medical Association (AMA)
Tunisi, Tahir S.. Hepatitis B vaccine in Saudi children. Bahrain Medical Bulletin. 1992. Vol. 14, no. 3, pp.86-87.
https://search.emarefa.net/detail/BIM-605622
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references : p. 87
Record ID
BIM-605622
